Found: 7
Select item for more details and to access through your institution.
Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease.
- Published in:
- Cell & Bioscience, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13578-022-00806-6
- By:
- Publication type:
- Article
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00720-3
- By:
- Publication type:
- Article
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00720-3
- By:
- Publication type:
- Article
Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 3, p. 1, doi. 10.1002/jmv.29498
- By:
- Publication type:
- Article
Production of a versatile SARS‐CoV‐2 main protease biosensor based on a dimerization‐dependent red fluorescent protein.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28342
- By:
- Publication type:
- Article
Letter to the Editor: Repurposing Tafenoquine as a Potential Inhibitor Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease via a Fluorescence Polarization Assay.
- Published in:
- Assay & Drug Development Technologies, 2023, v. 21, n. 8, p. 369, doi. 10.1089/adt.2023.103
- By:
- Publication type:
- Article
Validation of baicalein and oridonin as nonspecific SARS‐CoV‐2 main protease inhibitors.
- Published in:
- Phytotherapy Research, 2024, v. 38, n. 3, p. 1161, doi. 10.1002/ptr.7829
- By:
- Publication type:
- Article